Clinical Trials Directory

Trials / Sponsors / CrystalGenomics, Inc.

CrystalGenomics, Inc.

Industry · 17 registered clinical trials — 1 currently recruiting.

StatusTrialPhaseStarted
RecruitingAnti-PD-1 Antibody Therapies of Camrelizumab in Combination With Pemetrexed and Carboplatin as First-line Trea
Non Squamous Non Small Cell Lung Cancer
Phase 22023-08-23
CompletedPharmacokinetics and Safety of 'CG-745 IV' and 'CG-750' in Healthy Male Adults
Healthy
Phase 12019-12-16
CompletedDrug-Drug Interaction Study of "CG-651" in Healthy Volunteer
Healthy
Phase 12019-11-11
CompletedCG-549 Tablet Pharmacokinetics Study
Healthy
Phase 12019-09-23
CompletedStudy to Compare Safety and Pharmacokinetics of "CG1801" and "CGL1802" in Healthy Volunteers
Healthy
Phase 12018-12-17
CompletedDrug-Drug Interaction Study of "CG100650" in Healthy Volunteers
Healthy
Phase 12018-12-01
UnknownPhase 1/2 Study of CG200745 PPA for Myelodysplastic Syndrome
Myelodysplastic Syndrome
Phase 1 / Phase 22016-06-01
UnknownStudy of CG200745 PPA in Combination With Gemcitabine and Erlotinib for Advanced Pancreatic Cancer
Pancreatic Neoplasms
Phase 1 / Phase 22016-03-01
CompletedPhase III Study of CG100649 in Osteoarthritis Patients
Localized Primary Osteoarthritis of Hip, Localized Primary Osteoarthritis of Knee
Phase 32013-03-01
CompletedPhase 2a Study of CG400549 for the Treatment of cABSSSI Caused by Methicillin-resistant Staphylococcus Aureus
Skin Infection
Phase 22012-06-01
CompletedStudy of CG100649 Versus Celecoxib in Osteoarthritis Patients
Osteoarthritis
Phase 22011-04-01
UnknownExamine Maximum Tolerated Dose and Pharmacokinetic and Pharmacodynamic Profile
Solid Tumour
Phase 12010-09-01
CompletedPhase I Study on Multiple Oral Dosing of CG100649
Healthy
Phase 12010-06-01
CompletedMultiple Ascending Doses Study of CG400549
Healthy
Phase 12010-05-01
CompletedCG400549 Single Ascending Dose Study
Healthy
Phase 12009-10-01
CompletedTrial for Studying Pharmacokinetic Effects of Ketoconazole on CG100649
Healthy
Phase 12009-10-01
UnknownPhase II Study of CG100649 for Primary Osteoarthritis in Male Subjects
Osteoarthritis, Knee, Osteoarthritis, Hip
Phase 22007-10-01